Abstract
Cannabis or hemp has been employed medicinally in Ireland since at least the Anglo-Saxon era, more than 1000 years ago. Its use came to the fore, however when William B. O’Shaughnessy, an Irish physician in India, became familiar with the versatility of Indian hemp in the treatment of rheumatic diseases, tetanus, cholera and epilepsy in 1838. His knowledge, acquired through application of the scientific method combining ethnobotanical teachings, animal experimentation and clinical observations in humans, was quickly shared with colleagues in Ireland and England. This led in turn to rapid advances in therapeutics by Michael Donovan in neuropathic pain states, Dominic Corrigan in chorea and trigeminal neuralgia, Fleetwood Churchill in uterine hemorrhage, and Richard Greene in the use of cannabis as a prophylactic treatment of migraine. In each instance the observations of these past treatments are examined in light of 21st century advances in pathophysiology so that their rationale and scientific basis are clarified. The venerable Irish tradition of cannabis research is being carried on contemporaneously by numerous prominent scientists with the promise of important advancements yet to come.
Keywords
- Neuropathic Pain
- Trigeminal Neuralgia
- Delirium Tremens
- Irish Physician
- Infantile Convulsion
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, access via your institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Akerman S, Holland PR, Goadsby PJ (2007) Cannabinoid (CB1) receptor activation inhibits trigeminovascular neurons. J Pharmacol Exp Ther 320(1):64–71
Akerman S, Kaube H, Goadsby PJ (2003) Anandamide is able to inhibit trigeminal neurons using an in vivo model of trigeminovascular-mediated nociception. J Pharmacol Exp Ther 309(1):56–63
Akerman S, Kaube H, Goadsby PJ (2004) Anandamide acts as a vasodilator of dural blood vessels in vivo by activating TRPV1 receptors. Br J Pharmacol 142:1354–1360
Allen DE, Hatfield G (2004) Medicinal plants in folk tradition: an ethnobotany of britain and ireland. Timber Press, Portland, OR
Anonymous (1843) On the Cannabis indica, or indian hemp. Pharm J Trans 2:594–595
Anonymous (1870) Retirement of Mr. Donovan, of Dublin. Medical Press and Circular pp 447–448
Anonymous (1898) Asylum worthies. Mr. Richard Greene, F.R.C.P. Edin. The Hospital
Bacci A, Huguenard JR, Prince DA (2004) Long-lasting self-inhibition of neocortical interneurons mediated by endocannabinoids. Nature 431(7006):312–316
Baker D, Pryce G, Croxford JL, Brown P, Pertwee RG, Huffman JW, Layward L (2000) Cannabinoids control spasticity and tremor in a multiple sclerosis model. Nature 404(6773):84–87
Besnard P (1816) Observations on the promoting the cultivation of hemp and flax, and extending the linen and hempen manufactures in the south of Ireland. W. Folds and Sons, Cork, Ireland
Blake DR, Robson P, Ho M, Jubb RW, McCabe CS (2006) Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis. Rheumatol (Oxford) 45(1):50–52
Cameron CA (1886) History of the Royal College of Surgeons in Ireland and the Irish Schools of Medicine: Numerous Biographical Sketches: Also a Medical Bibliography. Fannin and Co., Dublin
Cassidy LM, Martiniano R, Murphy EM, Teasdale MD, Mallory J, Hartwell B, Bradley DG (2016) Neolithic and Bronze Age migration to Ireland and establishment of the insular Atlantic genome. Proc Natl Acad Sci U S A 113(2):368–373. doi:10.1073/pnas.1518445113
Churchill F (1849) Essays on the puerperal fever and other diseases peculiar to women. Selected from the writings of British authors previous to the close of the eighteenth century. Sydenham Society. Sydenham Society, London
Coakley D (1988) The irish school of medicine: outstanding practitioners of the 19th century. Town House, Dublin
Coakley D (1992) Irish masters of medicine. Town House, Dublin
Consroe P, Laguna J, Allender J, Snider S, Stern L, Sandyk R, Kennedy K, Schram K (1991) Controlled clinical trial of cannabidiol in Huntington’s disease. Pharmacol Biochem Behav 40(3):701–708
Corrigan D (1845a) Cases of chorea and tic-doloureux-treatment by tincture of Indian hemp and electro-magnetism, with observations. Dublin Hospital Gazette 10:143–145
Corrigan D (1845b) Treatment of chorea by the use of Cannabis indica. Medical Times 12:291–292
Corrigan D (1855) Chorée (emploi des inhalation de chloroforme dans le traitement de la).-Emploi du haschish dan la même maladie. J de Pharm et de Chim 27:312–314
Dalnoki O, Jacomet S (2002) Some aspects of Late Iron Age agriculture based on the first results of an archaeobotanical investigation at Corvin ter, Budapest, Hungary. Veg Hist Archaeobotany 11:9–15
Dark P (2000) The environment of Britain in the first millennium AD. Duckworth, London
Dastur JF (1962) Medicinal plants of India and Pakistan; A concise work describing plants used for drugs and remedies according to Ayurvedic, Unani and Tibbi systems and mentioned in British and American pharmacopoeias. D.B. Taraporevala Sons, Bombay
Dodick DW (2006) Clinical practice. Chronic daily headache. N Engl J Med 354(2):158–165
Donovan M (1832) A treatise on chemistry. Longman, Rees, Orme, Brown, Green and Longman, London, Cabinet Cyclopedia
Donovan M (1844) On the physical and medicinal qualities of Indian hemp (Cannabis indica) with observation on the best mode of administration and cases illustrative of its powers. Hodges and Smith, Dublin
Donovan M (1845) On the physical and medicinal qualities of Indian hemp (Cannabis indica); With observations on the best mode of administration, and cases illustrative of its powers. Dublin J Med Sci 26(368–402):459–461
Donovan M (1851) Observations on the resin of Indian hemp. Dublin Med Press 25(637):182–183
Farquhar-Smith WP, Egertova M, Bradbury EJ, McMahon SB, Rice AS, Elphick MR (2000) Cannabinoid CB(1) receptor expression in rat spinal cord. Mol Cell Neurosci 15(6):510–521
Fernandez-Ruiz J, Moreno-Martet M, Rodriguez-Cueto C, Palomo-Garo C, Gomez-Canas M, Valdeolivas S, Guaza C, Romero J, Guzman M, Mechoulam R, Ramos JA (2011) Prospects for cannabinoid therapies in basal ganglia disorders. Br J Pharmacol 163(7):1365–1378. doi:10.1111/j.1476-5381.2011.01365.x
Fride E, Sañudo-Peña MC (2002) Cannabinoids and endocannabinoids: behavioral and developmental aspects. In: Onaivi ES (ed) Biology of marijuana. From gene to hehavior. Taylor and Francis, London, pp 174–204
Friedman D, Devinsky O (2015) Cannabinoids in the treatment of epilepsy. N Engl J Med 373(11):1048–1058. doi:10.1056/NEJMra1407304
Glass M, Dragunow M, Faull RL (1997) Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain. Neuroscience 77(2):299–318
Gorman M (1983) Sir William B. O’Shaughnessy, pioneer chemical educator in India. Ambix 30 (Part 2):107–116
Gorman M (1984) Sir William Brooke O’Shaughnessy, F.R.S. (1809–1889), Anglo-Indian forensic chemist. Notes and Records of the Roayl Society of London 39 (1):51-64
Gottschling S (2011) Cannbinoide bei Kindern. Gute Erfahrungen bei Schmerzen, Spastik und in der Onkologie. Angew Schmerztherapie und Palliativmedizin 1:55–57
Grattan JHG, Singer CJ (1952) Anglo-Saxon magic and medicine. Illustrated specially from the semi-pagan text “Lacnunga,”. Publications of the Wellcome Historical Medical Museum. New ser., no. 3. Oxford University Press, London, New York
Greene JJ (1899) Celtic royal genealogy. http://wc.rootsweb.ancestry.com/cgi-bin/igm.cgi?op=GET&db=aet-t&id=I61019#s1
Greene R (1872) Cannabis indica in the treatment of migraine. Practitioner 41:267–270
Greene R (1874) Epilepsy and migraine: a clinical note. J Ment Sci 20:96–97
Greene R (1888) The treatment of migraine with Indian hemp. Practitioner 41:35–38
Izzo AA, Capasso F, Costagliola A, Bisogno T, Marsicano G, Ligresti A, Matias I, Capasso R, Pinto L, Borrelli F, Cecio A, Lutz B, Mascolo N, Di Marzo V (2003) An endogenous cannabinoid tone attenuates cholera toxin-induced fluid accumulation in mice. Gastroenterology 125(3):765–774
Izzo AA, Sharkey KA (2010) Cannabinoids and the gut: new developments and emerging concepts. Pharmacol Ther 126(1):21–38. doi:10.1016/j.pharmthera.2009.12.005 (S0163-7258(10)00006-9 [pii])
King A (2015) Medical marvel: the uses of cannabis continue to grow. Irish scientists are exploring the chemicals found in cannabis to develop drugs to treat pain, anxiety, MS and Alzheimer’s. Irish Times, Apr 16
Malfait AM, Gallily R, Sumariwalla PF, Malik AS, Andreakos E, Mechoulam R, Feldmann M (2000) The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis. Proc Natl Acad Sci U S A 97(17):9561–9566
Mikuriya TH (1973) Marijuana: Medical papers, 1839–1872. Medi-comp Press, Oakland, CA
Mikuriya TH (2004) Cannabis as a substitute for alcohol: a harm-reduction approach. Journal of Cannabis Therapeutics 4(1):79–93
Mills JH (2003) Cannabis Britannica: empire, trade, and prohibition 1800–1928. Oxford University Press, Oxford
Moloney MF (1919) Irish Ethno-Botany and the evolution of medicine in Ireland. M. H. Gill and Son, Dublin
Notcutt W, Langford R, Davies P, Ratcliffe S, Potts R (2012) A placebo-controlled, parallel-group, randomized withdrawal study of subjects with symptoms of spasticity due to multiple sclerosis who are receiving long-term Sativex(R) (nabiximols). Mult Scler 18(2):219–228. doi:10.1177/1352458511419700
Novotna A, Mares J, Ratcliffe S, Novakova I, Vachova M, Zapletalova O, Gasperini C, Pozzilli C, Cefaro L, Comi G, Rossi P, Ambler Z, Stelmasiak Z, Erdmann A, Montalban X, Klimek A, Davies P (2011) A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex((R))), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis. Eur J Neurol 18(9):1122–1131. doi:10.1111/j.1468-1331.2010.03328.x
Nurmikko TJ, Serpell MG, Hoggart B, Toomey PJ, Morlion BJ, Haines D (2007) Sativex successfully treats neuropathic pain characterised by allodynia: a randomised, double-blind, placebo-controlled clinical trial. Pain 133(1–3):210–220
O’Shaughnessy WB (1838–1840) On the preparations of the Indian hemp, or gunjah (Cannabis indica); their effects on the animal system in health, and their utility in the treatment of tetanus and other convulsive diseases. Transactions of the medical and physical society of Bengal:71–102, 421–461
O’Shaughnessy WB (1839) On the preparation of the Indian hemp, or Gunjah. J Asiatic Soc Bengal 8
O’Shaughnessy WB (1842) Bengal dispensatory and companion to the phamacopoeia. Allen, London
O’Shaughnessy WB (1843a) Indian hemp. Provincial Med J Retrospect Med Sci 5:397–398
O’Shaughnessy WB (1843b) On the preparations of the Indian hemp, or gunjah (Cannabis indica). Their effects on the animal system in health, and their utility in the treatment of tetanus and other convulsive diseases. Provincial Med J Retrospect Med Sci 5(122, 123):343–347, 363–369, 397–398
Pertwee RG (1972) The ring test: a quantitative method for assessing the ‘cataleptic’ effect of cannabis in mice. Br J Pharmacol 46(4):753–763
Pertwee RG (2001) Cannabinoids and the gastrointestinal tract. Gut 48(6):859–867
Porter BE, Jacobson C (2013) Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy. Epilepsy and behavior: E&B 29(3):574–577. doi:10.1016/j.yebeh.2013.08.037
Robson P (2005) Abrupt interruption of long-term treatment with Sativex was not associated with a consistent withdrawal syndrome or serious withdrawal symptoms in a sample of patients with multiple sclerosis. Multiple Sclerosis (submitted)
Rog DJ, Nurmiko T, Friede T, Young C (2005) Randomized controlled trial of cannabis based medicine in central neuropathic pain due to multiple sclerosis. Neurology 65(6):812–819
Rosenberg EC, Tsien RW, Whalley BJ, Devinsky O (2015) Cannabinoids and Epilepsy. Neurotherapeutics 12(4):747–768. doi:10.1007/s13311-015-0375-5
Rowland LP (ed) (2000) Merritt’s neurology, 10th edn. Lippincott, Williams and Wilkins, Philadelphia
Russo E (2002) Cannabis treatments in obstetrics and gynecology: A historical review. J Cannabis Ther 2(3–4):5–35
Russo EB (2001) Hemp for headache: An in-depth historical and scientific review of cannabis in migraine treatment. J Cannabis Ther 1(2):21–92
Russo EB (2004) Clinical endocannabinoid deficiency (CECD): Can this concept explain therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions? Neuroendocrinol Lett 25(1–2):31–39
Russo EB (2005) Cannabis in India: Ancient lore and modern medicine. In: Mechoulam R (ed) Cannabinoids as therapeutics. Birkhäuser Verlag, Basel, Switzerland, pp 1–22
Russo EB (2011) Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. Br J Pharmacol 163(7):1344–1364. doi:10.1111/j.1476-5381.2011.01238.x
Russo EB (2014) The pharmacological history of Cannabis. In: Pertwee R (ed) Handbook of cannabinoids. Oxford University Press, Oxford, United Kingdom
Russo EB (2016a) Cannabis and epilepsy: an ancient treatment returns to the fore. Epilepsy & behavior: E&B. doi:10.1016/j.yebeh.2016.09.040
Russo EB (2016b) Clinical endocannabinoid deficiency reconsidered: current research supports the theory in migraine, fibromyalgia, irritable bowel, and other treatment-resistant syndromes. Cannabis Cannabinoid Res 1:154–165. doi:10.1089/can.2016.0009
Russo EB, Guy GW, Robson PJ (2007) Cannabis, pain, and sleep: lessons from therapeutic clinical trials of Sativex, a cannabis-based medicine. Chem Biodivers 4(8):1729–1743. doi:10.1002/cbdv.200790150
Russo EB, Hohmann AG (2013) Role of cannabinoids in pain management. In: Deer T, Gordin V (eds) Comprehensive treatment of chronic pain by medical, interventional and behavioral approaches. Springer, New York, pp 181–197. doi:10.1007/978-1-4614-1560-2_18
Russo EB, Mead AP, Sulak D (2015) Current status and future of cannabis research. Clin Researcher (Apr):58–63
Sarchielli P, Pini LA, Coppola F, Rossi C, Baldi A, Mancini ML, Calabresi P (2007) Endocannabinoids in chronic migraine: CSF findings suggest a system failure. Neuropsychopharmacology 32(6):1384–1390. doi:10.1038/sj.npp.1301246 (1301246 [pii])
Wilde WR (1840) Narrative of a voyage to Madeira, Teneriffe, and along the shores of the Mediterranean, including a visit to Algiers, Egypt, Palestine, Tyre, Rhodes, Telmessus, Cyprus, and Greece. with observations on the present state and prospects of Egypt and Palestine, and on the climate, natural hisory, antiquities, etc. of the countries visited. William Curry, Jun. and Co., Dublin
Acknowledgements
I would like to thank Dr. Davis Coakley for his excellent scholarship on Irish medical history, as well as his provision of materials on Michael Donovan, and the hard-working staff of Inter-Library Loan, Mansfield Library, University of Montana for their assistance in providing rare and long-forgotten documents.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Russo, E.B. (2017). History of Cannabis as Medicine: Nineteenth Century Irish Physicians and Correlations of Their Observations to Modern Research. In: Chandra, S., Lata, H., ElSohly, M. (eds) Cannabis sativa L. - Botany and Biotechnology. Springer, Cham. https://doi.org/10.1007/978-3-319-54564-6_2
Download citation
DOI: https://doi.org/10.1007/978-3-319-54564-6_2
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-54563-9
Online ISBN: 978-3-319-54564-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)